CytoCatch™ is an innovative medical device that isolates and analyzes circulating tumor cells (CTCs) from blood samples. This technology, consisting of an isolation platform and an imaging system, automates the necessary steps to process the sample and captures CTCs for analysis. The captured cells can be used for molecular analysis to assess the genetic characteristics of the CTCs. CytoCatch™ has a wide range of applications in cancer diagnosis, patient monitoring, and personalized care. Delee, founded in 2017 and based in Sunnyvale, California, aims to revolutionize cancer management with their advanced blood test device.